Skip to main content
Book cover

Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma

  • Book
  • © 2012

Overview

  • Reviews major advances in molecular methods, using an evidence-based perspective
  • Explores powerful tools for determining treatment decisions
  • An essential resource for oncologists, dermatologists, pathologists, and melanoma researchers
  • Includes supplementary material: sn.pub/extras

Part of the book series: Current Clinical Pathology (CCPATH)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 249.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (23 chapters)

Keywords

About this book

This book describes both the technologies used in the discovery of melanoma biomarkers and the clinical application of these biomarkers for diagnosis and staging of disease, determination of prognosis, treatment planning, monitoring of response to therapy, identification of novel therapeutic targets and drug development. A broad range of biomarkers (DNA/chromosomal, mRNA, microRNA, mitochondrial DNA, epigenetic and protein) is outlined. As therapies for melanoma become increasingly more target specific, the identification, validation and use of biomarkers will invariably play a greater role in the management of patients with this disease. Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma is an essential resource for oncologists, dermatologists, dermatopathologists, general pathologists with an interest in melanoma, and melanoma researchers.

Reviews

From the reviews:

“This is a comprehensive overview of biomarkers as they relate to pathogenesis and clinical utility in the diagnosis, staging, and treatment of melanoma. … The audience is practitioners specializing in melanoma, including dermatologists, surgeons, and oncologists, as well as researchers in the field. … book broadly explores the role of molecular diagnostic techniques and specific biomarkers which may serve to facilitate more accurate diagnoses and identify early-stage melanoma patients with high risk for metastasis. … I highly recommend this book for melanoma clinicians and researchers.” (Susan M. Swetter, Doody’s Book Reviews, July, 2012)

Editors and Affiliations

  • Health Center, Department of Dermatology, University of Connecticut, Farmington, USA

    Michael J. Murphy

Bibliographic Information

  • Book Title: Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma

  • Editors: Michael J. Murphy

  • Series Title: Current Clinical Pathology

  • DOI: https://doi.org/10.1007/978-1-60761-433-3

  • Publisher: Humana Totowa, NJ

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer Science+Business Media, LLC 2012

  • Hardcover ISBN: 978-1-60761-432-6Published: 01 December 2011

  • Softcover ISBN: 978-1-4939-6186-3Published: 23 August 2016

  • eBook ISBN: 978-1-60761-433-3Published: 02 December 2011

  • Series ISSN: 2197-781X

  • Series E-ISSN: 2197-7828

  • Edition Number: 1

  • Number of Pages: XIV, 322

  • Topics: Pathology, Oncology, Dermatology

Publish with us